---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-22-000016"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-05-03T23:59:59+00:00"
generated_at: "2026-06-26T01:33:28.412041+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Moderna shareholders elect directors, approve executive compensation, ratify auditor at 2022 annual meeting

## Summary
- Directors elected: Noubar Afeyan (231.4M for), Stéphane Bancel (246.8M for), François Nader (234.2M for); broker non-votes 34.7M.
- Advisory vote on named executive officer compensation passed with 277.97M for (93% of votes cast).
- Ratification of Ernst & Young as auditor for FY2022 passed with 251.9M for (76% of votes cast).
- Shareholder proposal requesting report on IP transfer feasibility failed with 70.9M for (24% of votes cast).

## SEC filing metadata
- accession: 0001682852-22-000016
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-05-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000016/0001682852-22-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000016/mrna-20220428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-22-000016
- JSON: https://secwatch.observer/filing/0001682852-22-000016.json
- Plain text: https://secwatch.observer/filing/0001682852-22-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.